HHS Provides $77M in Grants for Substance Use Prevention, Mental Health
HHS awarded $77 million in SAMHSA grants for substance use prevention and treatment, mental health, suicide prevention and crisis services.
HHS awarded $77 million in SAMHSA grants for substance use prevention and treatment, mental health, suicide prevention and crisis services.
Empathy Health's $7.6 million round was led by HealthX Ventures and included participation from Nina Capital, Ikigai Healthcare Funds, American Heart Association Ventures, Suncoast Ventures, Cortado Ventures and Wilson Sonsini Investment Company.
Carrum Health has expanded its value-based substance use program to include cannabis, sedatives and stimulants.
If the guidelines for data sharing are not adhered to by providers, then all the work that has gone into revising this regulation will have been for nothing. But the road to compliance doesn’t have to be overwhelming. Here are three essential steps for healthcare leaders in navigating the soon-to-be Part 2 landscape.
Through its partnership with Pelago, Lantern’s clients can access Pelago’s substance use disorder treatment through Lantern’s specialty care platform.
Mental health company Lyra Health is now offering services for people struggling with cannabis, stimulants, opioids and nicotine.
Through a new partnership, Eleanor Health’s patients can access Thriveworks’ therapists for additional mental health support beyond their substance-use disorder, including couples and family counseling. Likewise, Thriveworks’ patients in Louisiana, Massachusetts, New Jersey, North Carolina, Ohio, Texas and Washington can receive substance-use disorder treatment from Eleanor Health.
Pelago's new contingency management program rewards patients for engaging in treatment, such as completing a survey, completing app check-ins, attending appointments and completing cognitive behavioral therapy exercises.